子宫内膜上皮内瘤变或非典型子宫内膜增生的管理:ACOG临床共识第5号
子宫内膜上皮内瘤变(EIN)或非典型子宫内膜增生(AEH)常为子宫内膜腺癌的癌前病变,子宫切除术是根治性治疗。考虑保守(保留生育)方案时需尽量排除子宫内膜癌,未手术者需孕激素治疗并密切监测;有限数据显示左炔诺孕酮宫内缓释装置退变率高于单用口服孕激素,周期性孕激素方案退变率低于连续口服治疗。
要点
- 子宫切除术是EIN-AEH的根治性治疗,保守治疗前应尽量排除子宫内膜癌。
- 未手术者需孕激素治疗(口服、宫内或联合)并密切监测,因进展为癌的风险高。
- 左炔诺孕酮宫内缓释装置退变率高于单用口服孕激素;周期性孕激素方案退变率低于连续口服治疗。
核心结论
- EIN-AEH常为子宫内膜腺癌的癌前病变,子宫切除术是其根治性治疗。
- 考虑保守(保留生育)治疗时,应尽量排除子宫内膜癌以避免对未知恶性肿瘤治疗不足。
- 因进展为癌的风险高,未手术者需孕激素治疗并密切监测。
- 生活方式调整实现减重和血糖控制可改善整体健康,并可能降低EIN-AEH和子宫内膜癌的风险。
研究设计与样本
- ACOG临床共识第5号,由美国妇产科医师学会(ACOG)制定。
主要发现
- 数据存在矛盾且有限,但研究显示左炔诺孕酮宫内缓释装置治疗较单用口服孕激素治疗退变率更高。
- 有限数据提示周期性孕激素方案较连续口服治疗退变率更低。
关键数值与推荐
- 子宫切除术是EIN-AEH的根治性治疗。
- 未手术者需孕激素治疗(口服、宫内或联合)并密切监测。
临床怎么用
- 妇产科医生及其他临床医生应告知患者:生活方式调整实现减重和血糖控制可改善整体健康,并可能降低EIN-AEH和子宫内膜癌的风险。
局限性
- 数据存在矛盾且有限。
- 有限数据提示周期性孕激素方案退变率较低。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Endometrial intraepithelial neoplasia (EIN) or atypical endometrial hyperplasia (AEH) often is a precursor lesion to adenocarcinoma of the endometrium. Hysterectomy is the definitive treatment for EIN-AEH. When a conservative (fertility-sparing) approach to the management of EIN-AEH is under consideration, it is important to attempt to exclude the presence of endometrial cancer to avoid potential undertreatment of an unknown malignancy in those who have been already diagnosed with EIN-AEH. Given the high risk of progression to cancer, those who do not have surgery require progestin therapy (oral, intrauterine, or combined) and close surveillance. Although data are conflicting and limited, studies have demonstrated that treatment with the levonorgestrel-releasing intrauterine device results in a higher regression rate when compared with treatment with oral progestins alone. Limited data suggest that cyclic progestational agents have lower regression rates when compared with continuous oral therapy. After initial conservative treatment for EIN-AEH, early detection of disease persistence, progression, or recurrence requires careful follow-up. Gynecologists and other clinicians should counsel patients that lifestyle modification resulting in weight loss and glycemic control can improve overall health and may decrease the risk of EIN-AEH and endometrial cancer.
引用
- Management of Endometrial Intraepithelial Neoplasia or Atypical Endometrial Hyperplasia: ACOG Clinical Consensus No. 5. Obstet Gynecol. 2023. PMID: 37590985. doi:10.1097/AOG.0000000000005297
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。